Clinical monitoring remains important to ensure both conditions are adequately controlled and to detect any individual variations in response to therapy
Nature 372:425432 Heymsfield SB, Greenberg AS, Fujioka K et al (1999) Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial
~ AlphaMD You've probably heard the locker room talk
How does Tirzepatide compare to other long-term treatments for its approved uses
Serious semaglutide risks include pancreatitis and gallbladder disease
First principles for therapy design Therapy design should follow three first principles: target the source before the sink, prioritizing isoform- or site-specific modulation of NOX enzymes, mitochondrial ROS sites, ER oxidoreductases, or iron handling rather than indiscriminate scavenging that can blunt physiological signalling (Sies et al